Metrika članka

  • citati u SCindeksu: 0
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[=>]
  • posete u poslednjih 30 dana:6
  • preuzimanja u poslednjih 30 dana:1
članak: 6 od 102  
Back povratak na rezultate
Medicinski pregled
2018, vol. 71, br. 11-12, str. 360-367
jezik rada: engleski
vrsta rada: originalan članak
doi:10.2298/MPNS1812360R


Inicijalno istraživanje somatizacije u srpskoj opštoj populaciji - prevalencija, manifestacije i prediktori
Univerzitet u Novom Sadu, Medicinski fakultet

e-adresa: nikola.rokvic@mf.uns.ac.rs

Sažetak

Uvod. Somatizacija je jedna od najprevalentnijih pretnji za zdravlje, subjektivno blagostanje i kvalitet života današnje opšte populacije. Mnogi psihološki konstrukti utiču na somatizaciju i njene ishode. Naš cilj je da utvrdimo kvalitet i prevalentnost somatizacije u opštoj populaciji Srbije koristeći Patient Health Quearionnaire-15 upitnik i da odredimo njene relacije sa crtama ličnosti i faktorima psihološkog distresa i blagostanja. Materijal i metode. Izradili smo dve studije. Studija 1 (N = 714) ima za cilj da odredi relacije između Velikih pet crta ličnosti, aleksitimije i somatizacije. Studija 2 (N = 807) imala je za cilj da utvrdi odnos faktora psihološkog distresa, odnosno depresivnosti, stresa i anksioznosti, zadovoljstva životom i subjektivne vitalnosti sa somatizacijom. Rezultati. U studiji 1 Neuroticizam i faktor 1 Toronto Alexithymia Scale, otežana identifikacija osećanja, najjače koreliraju sa somatizacijom i konstrukti mereni u ovoj studiji objašnjavaju 33,4% varijanse somatizacije. Anksioznost i stres koreliraju najsnažnije sa stepenom somatizacije u studiji 2. Regresioni model u studiji 2 ukazuje da mereni konstrukti objašnjavaju 44,7% varijanse. Najprevalentniji simptomi mereni Patient Health Questionnaire-15 su umor, bolovi u leđima i glavobolja. Zaključak. Nivoi somatizacije su malo iznad najviših merenih u opštoj populaciji, ali ispod nalaza merenja na kliničkoj populaciji. Prevalencija simptoma je u skladu sa dosadašnjim nalazima. Neuroticizam i anksioznost su tesno povezani sa somatizacijom. Dalja istraživanja treba da odrede dodatne faktore koji utiču na razvoj somatizacije.

Ključne reči

Reference

Naknadno pridodat članak: provera, normiranje i linkovanje referenci u toku.
Kocalevent DR, Hinz A, Brahler E. Standardization of a screening instrument (PHQ-15) for somatization in the general population. BMC Psychiatry. 2013;13:91.
Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jonsson B, et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011;21(9):655-79.
Dehoust MC, Schulz H, Härter M, Volkert J, Sehner S, Drabik A, et al. Prevalence of somatoform disorders in the elderly: results of a European study. Int J Methods Psychiatr Res. 2017;26(1):e1500.
Marple RL, Kroenke K, Lucey CR, Wilder J, Lucas CA. Concerns and expectations in patients presenting with physical complaints. Arch Intern Med. 1997;157(13):1482-8.
Van Ravesteijn H, Wittkampf K, Lucassen P, van de Lisdonk E, van den Hoogen H, van Weert H, et al. Detecting somatoform disorders in primary care with the PHQ-15. Ann Farm Med. 2009;7(3):232-8.
Han C, Pae CU, Patkar AA, Masand PS, Kim KW, Joe SH, et al. Psychometric properties of the Patient Health Questionnaire-15 (PHQ-15) for measuring the somatic symptoms of psychiatric outpatients. Psychosomatics. 2009;50(6):580-5.
Kroenke K, Spiltzer RL, Williams JB. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med. 2002;64(2):258-66.
Schumacher S, Rief W, Brähler E, Martin A, Glaesmer H, Mewes R. Disagreement in doctor’s and patient’s rating about medically unexplained symptoms and health care use. Int J Behav Med. 2013;20(1):30-7.
Steinbrecher N, Koerber S, Frieser D, Hiller W. The prevalence of medically unexplained symptoms in primary care. Psychosomatics. 2011;52(3):263-71.
Hinz A, Ernst J, Glaesmer H, Brähler E, Rauscher FG, Petrowski K, et al. Frequency of somatic symptoms in the general population: normative values for the Patient Health Questionnaire-15 (PHQ-15). J Psychosom Res. 2017;96:27-31.
Claassen-van Dessel N, van der Wouden JC, Hoekstra T, Dekker J, van der Horst HE. The 2-year course of Medically Unexplained Physical Symptoms (MUPS) in terms of symptom severity and functional status: results of the PROSPECT cohort study. J Psychosom Res. 2018;104:76-87.
Žikić M, Rabi Žikić T. Meteoropathy and meteorososensitive persons. Med Pregl. 2018;71(3-4):131-5.
Fergus TA, Limbers CA, Griggs JO, Kelley LP. Somatic symptom severity among primary care patients who are obese: examining the unique contributions of anxiety sensitivity, discomfort intolerance, and health anxiety. J Behav Med. 2008;41(1):43-51.
Lowe B, Spitzer RL, Williams JB, Mussell M, Schellberg D, Kroenke K. Depression, anxiety and somatization in primary care: syndrome overlap and functional impairment. Gen Hosp Psychiatry. 2008;30(3):191-9.
Kroenke K, Spitzer RL, Williams JB, Monahan PO, Lowe B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007;146(5):317-25.
Lowe B, Grafe K, Zipfel S, Spitzer RL, Herrmann-Lingen C, Wittel S, et al. Detecting panic disorder in medical and psychosomatic outpatients: comparative validation of the Hospital Anxiety and Depression Scale the Patient Health Questionnaire, a screening question and physicians diagnosis. J Psychosom Res. 2003;55(6):515-9.
Hyphantis T, Kroenke K, Papatheodorou E, Paika V, Theocharopolous N, Ninou A, et al. Validity of the Greek version of the PHQ 15-item Somatic Symptom Severity Scale in patients with chronic medical conditions and correlations with emergency department use and illness perceptions. Compr Psychiatry. 2014;55:1950-9.
Nordin S, Palmquist E, Nordin M. Psychometric evaluation and normative data for a Swedish version of the Patient Health Questionnaire 15-item Somatic Symptom Severity Scale. Scand J Psychol. 2013;54(2):112-7.
Henry JD, Crawford JR. The short-form version of the Depression Anxiety Stress Scales (DASS-21): construct validity and normative in a large non-clinical sample. Br J Clin Psychol. 2005;44(Pt 2):227-39.
Bener A, Al-Kazaz M, Ftouni D, Al-Harthy M, Dafeeah EE. Diagnostic overlap of depressive, anxiety, stress and somatoform disorders in primary care. Asia Pac Psychiatry 2013;5(1):E29-38.
Koh JS, Ko HJ, Wang SM, Cho KJ, Kim JC, Lee SJ, et al. The association of personality trait on treatment outcomes in patients with chronic prostatitis/chronic pelvic pain syndrome: an exploratory study. J Psychosom Res. 2014;76(2):127-33.
De Gucht V. Stability of neuroticism and alexithymia in somatization. Compr Psychiatry. 2003;44(6):466-71.
Kajanoja J, Scheinin NM, Karlsson L, Karsslon H, Karukivi M. Alexithymia as a health risk and resilience factor: response to Dr. Davydov. J Psychosom Res. 2017;101:135-6.
Rokvić N, Jovanović T. Alexithymia measured with the TAS-20 questionnaire: determining the validity of the factor structure and its relation of life satisfaction and the Big Five personality traits. Psihološka istraživanja. 2018;21(1):23-40.
Interian A, Allen LA, Gara MA, Excobar JI, Diaz-Martinez AM. Somatic complaints in primary care: further examining the validity of the Patient Health Questionnaire (PHQ-15). Psychosomatics. 2006;47(5):392-8.
Kocalevent RD, Hinz A, Brahler E. Standardization of the depression screener Patient Health Questionnaire (PHQ-9) in the general population. Gen Hosp Psychiatry. 2013;35(5):551-5.
Trajanović NN, Djurić V, Latas M, Milovanović S, Jovanović AA, Djurić D. Serbian translation of the 20-item Toronto Alexithymia Scale: psychometric properties and the new methodological approach in translating scales. Srp Arh Celok Lek. 2013;141(5-6):366-70.
Jovanović V, Gavrilov-Jerković V, Žuljevic D, Brdarić D. Psychometric evaluation of the Depression Anxiety Stress Scales-21 (DASS-21) in a Serbian student sample. Psihologija. 2014;47(1):93-112.
Diener E, Emmons RA, Larsen RJ, Griffin S. The satisfaction with Life Scale. J Pres Assess. 1985;49(1):71-5.
Jovanović V. The validity of the satisfaction with Life Scale in adolescents and a comparison with a single item life satisfaction measures: a preliminary study. Qual Life Res. 2016;25(12):3173-80.
Ryan RM, Frederick C. On energy, personality, and health: subjective vitality as a dynamic reflection of well-being. J Pers. 1997;65(3):529-65.
Bostic TJ, McGartland Rubio D, Hood M. A validation of the Subjective Vitality Scale using structural equation modeling. Soc Indic Res. 2000;52(3):313-24.
Lockenhoff CE, Sutin AR, Ferrucci L, Costa PT. Personality traits and subjective health in later years: the association between NEO-PI-R and SF-36 in advanced age is influenced by health status. J Res Pers. 2008;42:1334-46.
Sigmon ST, Dorhofer DM, Rohan KJ, Boulard NE. The impact of anxiety sensitivity, bodily expectations, and cultural beliefs on menstrual symptom reporting: a test of the menstrual reactivity hypothesis. J Anxiety Disord. 2000;14(6):615-33.